tweenvest

IQVIA Holdings Inc. (NYSE: IQV)

Salud · Herramientas y servicios para ciencias de la vida · US

257,84 $

+0,09 % hoy · +18,7 % 1 año

Ficha pública
Un resumen gratuito de IQVIA Holdings Inc., con datos del 15 nov 2026. El análisis completo está en la app.Abrir en la app

IQVIA Holdings Inc. (NYSE: IQV) opera en la industria de herramientas y servicios para ciencias de la vida dentro del sector salud. Su valor en bolsa es de 42,49 mil M $ y tiene 94.000 empleados.

En los últimos doce meses la acción ha subido un 18,7 % y ha cotizado entre 154,50 y 284,50.

Tweenvest puntúa a IQVIA Holdings Inc. en cuatro factores: calidad 66/100, valor 59/100, crecimiento 54/100. Su punto más fuerte es calidad.

Evolución de la cotización de IQV

21 nov 2025 · 224,90Cierres semanales 157,77 – 279,3618 nov 2026 · 257,84

Cifras clave

Capitalización
42,49 mil M $
Ingresos (últ. 12 m)
17,31 mil M $
PER
31,24
BPA
8,23
Rent. por dividendo
—
Beta (5 años)
1,17
Máximo 52 semanas
284,50 $
Mínimo 52 semanas
154,50 $
Volumen medio (3 m)
—
Acciones en circulación
164,80 M
Empleados
94.000
Próximos resultados
—

Sobre IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

ISIN
US46266C1053
Cotiza desde
9 may 2013
Bolsa
New York Stock Exchange
Divisa
USD
EmpresaCapitalizaciónPrecioDía
Lonza Group AGSWX: LONN55,21 mil M $666,60 CHF+0,54 %
Agilent Technologies, Inc.NYSE: A49,99 mil M $177,33 $+2,97 %
Samsung Biologics Co.,Ltd.KOSE: A20794048,97 mil M $1.414.000,00 ₩-0,63 %
Waters CorporationNYSE: WAT45,81 mil M $466,12 $+0,00 %
Mettler-Toledo International Inc.NYSE: MTD34,55 mil M $1737,26 $+1,42 %
Divi's Laboratories LimitedNSEI: DIVISLAB32,21 mil M $11.442,00 Rs-0,37 %
Illumina, Inc.NasdaqGS: ILMN31,75 mil M $210,01 $+3,65 %
West Pharmaceutical Services, Inc.NYSE: WST28,14 mil M $404,02 $-2,44 %

Ver todas las empresas de herramientas y servicios para ciencias de la vida →